Overview

""A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth.""-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers. ""From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can.""-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen. Written by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry - biotechnology - that's on the verge of living up to its monumental promise to change the world as we know it.

Full Product Details

9780738204826

Table of Contents

Reviews

A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth. -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can. -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen

""A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."" -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers ""From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."" -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen""

Author Information

Cynthia Robbins-Roth, Ph.D., is the founder of BioVenture Consultants, which provides strategic planning and financial assessment to biotech start-ups, pharmaceutical companies, and venture-capital firms. Her biotech column appears regularly in Forbes magazine, and Forbes ASAP recently named her one of the top twenty-five biotech All-Stars of 1999. She lives in San Mateo, California.

Tab Content 6

Countries Available